🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00876850
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
An open label, balanced, randomized, two-treatment, two-period, two-sequenc...
Status
Completed
Location
Multiple Locations
Start Date
2012-11
Trial ID
NCT02322619
Treatments Being Tested
A Phase III trial to demonstrate the safety and efficacy of PTK 0796 in the...
Status
Terminated
Location
Paratek Recruiting Site
Start Date
2009-04-04
Trial ID
NCT00865280
Treatments Being Tested
The study will investigate whether administration of clazosentan can affect...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2018-09-18
Trial ID
NCT03657446
Treatments Being Tested
The effect of multiple oral administration of two doses of CG5503 PR (prolo...
Status
Completed
Location
DE001 - Contract research organisation
Start Date
2003-03
Trial ID
NCT03951402
This is a single-center, randomized, partially double-blind, placebo and ac...
Status
Completed
Location
California Clinical Trials Medical Group, Inc.
Start Date
2024-09-25
Trial ID
NCT06591845
Treatments Being Tested
This dedicated T/QT study will investigate the effect of relacorilant on ca...
Status
Completed
Location
Single Site
Start Date
2021-01-22
Trial ID
NCT04795479
Treatments Being Tested
This study was to evaluate effects of Sativex on electrocardiogram (ECG) tr...
Status
Completed
Location
DecisionLine Clinical Research Corporation
Start Date
2007-12
Trial ID
NCT01322139
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2015-02
Trial ID
NCT02342886